Log In | Subscribe | Sitemap
Retail Updates

 Bpk Danang Widodo memberikan cenderamata kepada Bpk Mahesh Agarwal 

>> more
QASA Market Updates
  • Afghanistan is attempting to increase trading billateral and investment with Indonesia
  • UNCTAD: Dari Posisi 8, Indonesia Kini Posisi 4 Negara Tujuan Investasi
  • UNCTAD: From 8th Rank, Indonesia is at 4th position as an investment destination country
• Samples  • Agriculture  • Heavy Equipment  • Packaging  • Electronic  • Home Appliance  • Infrastructure  • Shariah Finance  • Banking  • Telecommunication  • Manufacture  • Mining  • Garment  • Retail  • Wholesale  • Construction  • Finance  • Investment  • poultry  • Automotive  • FMCG  • Information Technology  • Services  • Transportation  • Electric  • Pharmaceutical  • Advertising  • Regulation  • Commercial Economy  • Property  • Food & Beverage  • Chemical  • Economy 
  • 2017
  • 2015
  • 2014
  • 2012
  • 2011
  • 2010
  • QASA Market Updates • Updates • Pharmaceutical

    Nowaday, pharmaceutical import products still dominated in Indonesia market.

    As the largest public health product company in Southeast Asia, PT Kalbe Farma Tbk continues to innovate to improve products and services.

    Although the implementation of National Health Insurance (JKN) System has been effectived, pharmaceutical company sales growth in 2014 is still slowing compared to last year.

    Applicability of the National Social Security System (SJSN) in 2014 is expected to inflate demand for generic drugs

    Investment by foreign pharmaceutical producers are valued at U.S. $ 44 million

    Some drug manufacturers began to increase production capacity

    Time to time continue to show improvement

    PT Rohto Laboratories Indonesia and PT L'Oreal Indonesia, will build the plant this year

    Indonesia's pharmaceutical market is expected to grow in the fourth highest position in the Asia Pacific region

    National cosmetics sales in the first semester of 2012 is expected to grow 14.9 percent

    The potential for market growth in generic drugs and medical devices is estimated to reach Rp 9.2 billion

    The production cost of medicine year-to-date is relatively stable

    PT Kimia Farma Tbk plans to form a joint venture with Japanese companies led by Mitsui Corporation

    PT Indofarma Tbk plans to build two manufactories in the second semester of 2012

    The Minister of Health estimates the medical equipment market will grow 5% year-on-year to Rp 7 trillion this year

    PT Kimia Farma Tbk and PT Tigaka Distrindo Perkasa signed a joint venture agreement with Tianjin Pharmaceutical Group Co.,Ltd

    PT Bayer Indonesia is targeting sales in the next five years to reach  400 million Euro

    Local pharmaceutical companies control the prescription drugs market in Indonesia

    Sales of generic drugs is projected to triple in 2014

    Sales of prescription drugs in Indonesia in 2012 is projected at around Rp 28 trillion

    Page << 1 | 2 | 3 >>